Newly Formed Company Poised for Sustained Growth With a Strengthened Balance Sheet, Resolved Litigation Overhang, Diversified Portfolio of Medicines and a Deep New Product Pipeline MALVERN, Pa., April 23, 2024  /PRNewswire/ — Endo, Inc. (“Endo” or the “Company”), a newly formed entity, today announced that it has successfully completed the previously announced acquisition of substantially all of